2023-09-01 09:06:06 ET
More on Illumina
- Illumina, Inc. ( ILMN ) UBS MedTech, Tools and Genomics Summit 2023 Conference (Transcript)
- Illumina, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Illumina, Inc.: Collapsing Margins, Rising Debt, Legal Setbacks, And Downward Momentum
- Illumina under SEC investigation over GRAIL acquisition
- Illumina cuts full-year guidance; shares fall 6% after hours
- Seeking Alpha’s Quant Rating on Illumina
- Earnings data for Illumina
For further details see:
Illumina added to Evercore’s Tactical Outperform list on a potential CEO hire